UBS O'Connor’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Hold	0	–	–	–	407
2024 Q2	–	Hold	0	–	–	–	435
2023 Q4	–	Hold	0	–	–	–	431
2023 Q3	–	Hold	0	–	–	–	480
2016 Q2	–	Sell	-15,292	Closed	-$960K	–	369
2016 Q1	$960K	Buy	+15,292	New	+$960K	0.02%	316